Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study

199134 citationsJournal Article

Authors

Good health and well-being

Published in: European Neuropsychopharmacology

Volume 1, Issue 4, pp. 511-517

Field-Weighted Citation Impact: 1.91